Serum-soluble interleukin-2 receptor (sIL-2R) level determines clinical outcome in patients with aggressive non-Hodgkin’s lymphoma: in combination with the International Prognostic Index

✍ Scribed by Hideko Goto; Hisashi Tsurumi; Masao Takemura; Yoriko Ino-Shimomura; Senji Kasahara; Michio Sawada; Toshiki Yamada; Takeshi Hara; Kenji Fukuno; Naoe Goto; Masataka Okuno; Tsuyoshi Takami; Mitsuru Seishima; Hisataka Moriwaki

• Publisher: Springer-Verlag
• Year: 2004
• Tongue: English
• Weight: 244 KB
• Volume: 131
• Category: Article
• ISSN: 1432-1335
• DOI: 10.1007/s00432-004-0600-9